Powered by

Weekly: Aptose Biosciences down 13.6% in 2 weeks September 21, 2018 17:00 EDT

Sep 21, 2018 - News Bites Canadian Markets


Aptose Biosciences Inc. (TSX:APS), Canada's 16th largest Biotechnology company by market cap, extended its slide in the past week ended Friday, shedding an additional 5.0c (or 1.4%) to close at CAD3.50. The shares have plummeted 55.0c (or 13.6%) over the past two weeks. Compared with the S&P/TSX 60 Index which rose 5.8 points (or 0.6%) in the two weeks, this represented a relative price change of -14.2%. The volume was 0.1 times average trading per week of 2.1 ...